Intrinsic Alpha

Humana Inc.

NYSE:HUM

Medical - Healthcare Plans

Healthcare
$389.91 +0.19%

+$0.70 today

Market cap
$46.83B
Beta
0.77
P/E (TTM)
38.6
EPS (TTM)
$9.39
Dividend yield
0.98%
52W Low $163.11High $380.86

Volume 2.10M

Average 1.72M

Returns on capital

Humana Inc. management

Start with the returns management earns on the capital it controls, then review the people, their trades, and growth quality.

Return Metrics

ROE, ROIC & ROA over time

Management
Older years hidden. Sign in to unlock

ROE

6.7%

avg 15.7%

ROIC

3.1%

avg 7.3%

ROA

2.4%

avg 6.0%

Analysis

ROE is currently the strongest return metric at 6.7% versus its period average of 15.7%. 0 of 3 return metrics are above their quality threshold, which helps indicate how efficiently the company turns capital and assets into profit.

Leadership

Who runs the company?

Review the executive team, tenure, compensation, and ownership.

Management

Key executives, compensation & ownership

NameTitleCompensationAgeShares OwnedOwnership %

Celeste Mellet

Chief Financial OfficerUSD 8.27M4939.64K0.03%

Japan Mehta

Chief Information OfficerUSD 5.66M4517.18K0.01%

James A. Rechtin

President, Chief Executive Officer & DirectorUSD 4.89M5563.94K0.05%

Michelle O'Hara

Chief Human Resources OfficerUSD 4.08M50——

Bruce Dale Broussard

Strategic AdvisorUSD 4.06M64——

Sanjay K. Shetty

President of CenterWellUSD 2.09M5222.09K0.02%

Joseph C. Ventura

Chief Legal OfficerUSD 840.36K4921.47K0.02%

Bobby Mukundan

Senior Vice President & Chief Technology Officer————

John-Paul W. Felter

Senior Vice President, Chief Accounting Officer & Controller—437.48K<0.01%

Lisa Stoner

Vice President of Investor Relations————

Compensation is shown in the reported currency; data updated Nov 7, 2026.

Ownership uses each executive's latest SEC Form 4 holding only when the full name maps to one reporting CIK; latest matched holding Nov 9, 2026.

Insider trading

Are insiders buying or selling?

Follow recent insider purchases and sales reported on Form 4.

Insider Trading

SEC Form 4 transactions — last 12 months

Buys

1

$150,016.05

Sells

2

$2.58M

Net Transaction Value

−$2.43M

Net selling

Most Active

Frederick Wayne A.I.

1 transactions

Transactions sorted by date, descending.

Open-market insider purchases and sales reported during the last 12 months
Type
Nov 10, 26

Frederick Wayne A.I.

Direct

Sell$193.9K
Nov 9, 26

Ventura Joseph C

Direct

Sell$2.4M
Feb 23, 26

Shetty Sanjay K

Direct

Buy$150K

Summary

Insiders reported 1 buys worth $150,016.05 and 2 sells worth $2.58M over the last 12 months. That adds up to net selling of $2.43M. Frederick Wayne A.I. was the most active insider with 1 transactions.

Growth analysis

Is management growing the business?

Compare historical growth with analyst forecasts across revenue, earnings, and cash flow.

Growth Analysis

Historical CAGR & forward analyst estimates

Metric 10yr 5yr3yr Fwd Est.
EPSN/AN/A-23.6%
+31.1% (5yr)4 analysts
RevenueN/AN/A+11.7%
+10.4% (5yr)10 analysts
Net IncomeN/AN/A-24.9%
+31.1% (5yr)10 analysts
EBITN/AN/A-25.9%
+34.6% (5yr)10 analysts

Analysis

Recent growth has been strongest in Revenue at +11.7% over three years. Forward estimates point to EBIT at +34.6% (5yr), giving you a quick check on whether expectations are accelerating or cooling.

Competitors

Who does Humana Inc. compete with?

Open similar companies to compare how their management teams allocate capital.

Questions

Management questions

Common questions about HUM's management, answered from reported figures.

Who manages HUM?

Humana Inc. (HUM) lists 10 active executives. The top listed executive is Bobby Mukundan, Senior Vice President & Chief Technology Officer.

Are HUM insiders buying or selling?

Recent insider activity shows net selling of $8.40M.